T-CELL-RICH LARGE B-CELL LYMPHOMA - A STUDY OF 30 CASES, SUPPORTING ITS HISTOLOGIC HETEROGENEITY AND LACK OF CLINICAL DISTINCTIVENESS

被引:95
作者
KRISHNAN, J [1 ]
WALLBERG, K [1 ]
FRIZZERA, G [1 ]
机构
[1] ARMED FORCES INST PATHOL,DEPT HEMATOPATHOL,WASHINGTON,DC
关键词
T-CELL-RICH B-CELL LYMPHOMAS; IMMUNOPHENOTYPE OF LYMPHOMAS; POLYMERASE CHAIN REACTION;
D O I
10.1097/00000478-199405000-00004
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
To determine whether correlations existed between morphologic and immunophenotypic findings and clinical characteristics, 30 cases of T-cell-rich large B-ceI1 lymphomas (TBL) were evaluated by histopathology, immunostaining, and polymerase chain reaction on paraffin-embedded material. All were characterized by a polymorphic cell composition, including a variable mixture of small and large lymphoid cells and reactive cell. Most cases (87%) fitted into one of three main histologic types of non-Hodgkin's lymphoma (diffuse, mixed cell; diffuse, large cell; follicular and diffuse, mixed cell), and one group of eight cases had the prototypic features described by Ramsay et al. (17). All cases showed a component of large CD20(L26)(+) MB2(+) B cells in a predominant background of reactive T cells (>50% of the total lymphoid forms). Clonality was demonstrated by light chain restriction in 67% of cases and by rearrangement of the immunoglobulin heavy chain gene and bcl-2 gene in 64% and 28% of cases, respectively. The patients were predominantly men (70%), ages 18-83 years (median of 62.5), and were initially seen predominantly with nodal disease (and extranodal involvement in 20%) at advanced stages (III-IV: 77%). Treatment was mostly aggressive chemotherapy, and the outcomes were favorable (84% alive and well). These features are not distinctive as compared with those of typical large-cell lymphoma, nor did subgroups within the series (prototypic cases versus others; cases with less [less than or equal to 70%] or more [>70%] T-cell infiltration) significantly differ in clinical presentation or outcome. Thus, this study confirms that TBL, while useful as a diagnostic variant to be distinguished from both peripheral T-cell lymphoma and Hodgkin's disease, is a heterogeneous assortment of diverse histopathologic categories rather than a clinicopathologic entity. The term ''T-cell rich'' might, however, be usefully retained as a morphologic specification to be added to recognized histologic categories of lymphoma.
引用
收藏
页码:455 / 465
页数:11
相关论文
共 28 条
  • [21] DETERMINATION OF B-CELL CLONALITY IN PARAFFIN-EMBEDDED LYMPH-NODES USING THE POLYMERASE CHAIN-REACTION
    REED, TJ
    REID, A
    WALLBERG, K
    OLEARY, TJ
    FRIZZERA, G
    [J]. DIAGNOSTIC MOLECULAR PATHOLOGY, 1993, 2 (01) : 42 - 49
  • [22] T-CELL RICH B-CELL LYMPHOMA
    SCARPA, A
    BONETTI, F
    ZAMBONI, G
    MENESTRINA, F
    CHILOSI, M
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1989, 13 (04) : 335 - 337
  • [23] SCHMID C, 1991, AM J PATHOL, V139, P1281
  • [24] SHAHAB I, 1993, MODERN PATHOL, V6, pA100
  • [25] DETECTION OF SPECIFIC T(14-18) CHROMOSOMAL TRANSLOCATIONS IN FIXED TISSUES
    SHIBATA, D
    HU, E
    WEISS, LM
    BRYNES, RK
    NATHWANI, BN
    [J]. HUMAN PATHOLOGY, 1990, 21 (02) : 199 - 203
  • [26] DETECTION OF SPECIFIC SEQUENCES AMONG DNA FRAGMENTS SEPARATED BY GEL-ELECTROPHORESIS
    SOUTHERN, EM
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1975, 98 (03) : 503 - +
  • [27] STANSFELD AG, 1988, LANCET, V1, P292
  • [28] MACOP-B TREATMENT IN DIFFUSE LARGE-CELL LYMPHOMA - IDENTIFICATION OF PROGNOSTIC GROUPS IN AN ITALIAN MULTICENTER STUDY
    VITOLO, U
    BERTINI, M
    BRUSAMOLINO, E
    CAVALLERO, GB
    COMOTTI, B
    GALLO, E
    GHIO, R
    LEVIS, A
    LUXI, G
    MENEGHINI, V
    NOVERO, D
    ORSUCCI, L
    ROTASCALABRINI, D
    TARELLA, C
    TODESCHINI, G
    VIERO, P
    BARBUI, T
    BERNASCONI, C
    PERONA, G
    PILERI, A
    RESEGOTTI, L
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (02) : 219 - 227